366 related articles for article (PubMed ID: 12959414)
1. New hepatocyte in vitro systems for drug metabolism: metabolic capacity and recommendations for application in basic research and drug development, standard operation procedures.
Gebhardt R; Hengstler JG; Müller D; Glöckner R; Buenning P; Laube B; Schmelzer E; Ullrich M; Utesch D; Hewitt N; Ringel M; Hilz BR; Bader A; Langsch A; Koose T; Burger HJ; Maas J; Oesch F
Drug Metab Rev; 2003; 35(2-3):145-213. PubMed ID: 12959414
[TBL] [Abstract][Full Text] [Related]
2. Hepatocytes cultured in alginate microspheres: an optimized technique to study enzyme induction.
Ringel M; von Mach MA; Santos R; Feilen PJ; Brulport M; Hermes M; Bauer AW; Schormann W; Tanner B; Schön MR; Oesch F; Hengstler JG
Toxicology; 2005 Jan; 206(1):153-67. PubMed ID: 15590115
[TBL] [Abstract][Full Text] [Related]
3. The suitability of hepatocyte culture models to study various aspects of drug metabolism.
Nussler AK; Wang A; Neuhaus P; Fischer J; Yuan J; Liu L; Zeilinger K; Gerlach J; Arnold PJ; Albrecht W
ALTEX; 2001; 18(2):91-101. PubMed ID: 11378681
[TBL] [Abstract][Full Text] [Related]
4. Cooperation of liver cells in health and disease.
Kmieć Z
Adv Anat Embryol Cell Biol; 2001; 161():III-XIII, 1-151. PubMed ID: 11729749
[TBL] [Abstract][Full Text] [Related]
5. Establishment of a novel in vitro system for studying the interaction of xenobiotic metabolism of liver and intestinal microflora.
Laube B; Winkler S; Ladstetter B; Scheller T; Schwarz LR
Arch Toxicol; 2000 Sep; 74(7):379-87. PubMed ID: 11043493
[TBL] [Abstract][Full Text] [Related]
6. Towards an extended functional hepatocyte in vitro culture.
Miranda JP; Leite SB; Muller-Vieira U; Rodrigues A; Carrondo MJ; Alves PM
Tissue Eng Part C Methods; 2009 Jun; 15(2):157-67. PubMed ID: 19072051
[TBL] [Abstract][Full Text] [Related]
7. Vitellogenin synthesis in primary cultures of fish liver cells as endpoint for in vitro screening of the (anti)estrogenic activity of chemical substances.
Navas JM; Segner H
Aquat Toxicol; 2006 Oct; 80(1):1-22. PubMed ID: 16950525
[TBL] [Abstract][Full Text] [Related]
8. Three-dimensional co-culture of primary human liver cells in bioreactors for in vitro drug studies: effects of the initial cell quality on the long-term maintenance of hepatocyte-specific functions.
Zeilinger K; Sauer IM; Pless G; Strobel C; Rudzitis J; Wang A; Nüssler AK; Grebe A; Mao L; Auth SH; Unger J; Neuhaus P; Gerlach JC
Altern Lab Anim; 2002; 30(5):525-38. PubMed ID: 12405881
[TBL] [Abstract][Full Text] [Related]
9. Extending hepatocyte functionality for drug-testing applications using high-viscosity alginate-encapsulated three-dimensional cultures in bioreactors.
Miranda JP; Rodrigues A; Tostões RM; Leite S; Zimmerman H; Carrondo MJ; Alves PM
Tissue Eng Part C Methods; 2010 Dec; 16(6):1223-32. PubMed ID: 20184401
[TBL] [Abstract][Full Text] [Related]
10. Serum-free culture of primary human hepatocytes in a miniaturized hollow-fibre membrane bioreactor for pharmacological in vitro studies.
Lübberstedt M; Müller-Vieira U; Biemel KM; Darnell M; Hoffmann SA; Knöspel F; Wönne EC; Knobeloch D; Nüssler AK; Gerlach JC; Andersson TB; Zeilinger K
J Tissue Eng Regen Med; 2015 Sep; 9(9):1017-26. PubMed ID: 23165723
[TBL] [Abstract][Full Text] [Related]
11. Upflow anaerobic sludge blanket reactor--a review.
Bal AS; Dhagat NN
Indian J Environ Health; 2001 Apr; 43(2):1-82. PubMed ID: 12397675
[TBL] [Abstract][Full Text] [Related]
12. Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME.
Godoy P; Hewitt NJ; Albrecht U; Andersen ME; Ansari N; Bhattacharya S; Bode JG; Bolleyn J; Borner C; Böttger J; Braeuning A; Budinsky RA; Burkhardt B; Cameron NR; Camussi G; Cho CS; Choi YJ; Craig Rowlands J; Dahmen U; Damm G; Dirsch O; Donato MT; Dong J; Dooley S; Drasdo D; Eakins R; Ferreira KS; Fonsato V; Fraczek J; Gebhardt R; Gibson A; Glanemann M; Goldring CE; Gómez-Lechón MJ; Groothuis GM; Gustavsson L; Guyot C; Hallifax D; Hammad S; Hayward A; Häussinger D; Hellerbrand C; Hewitt P; Hoehme S; Holzhütter HG; Houston JB; Hrach J; Ito K; Jaeschke H; Keitel V; Kelm JM; Kevin Park B; Kordes C; Kullak-Ublick GA; LeCluyse EL; Lu P; Luebke-Wheeler J; Lutz A; Maltman DJ; Matz-Soja M; McMullen P; Merfort I; Messner S; Meyer C; Mwinyi J; Naisbitt DJ; Nussler AK; Olinga P; Pampaloni F; Pi J; Pluta L; Przyborski SA; Ramachandran A; Rogiers V; Rowe C; Schelcher C; Schmich K; Schwarz M; Singh B; Stelzer EH; Stieger B; Stöber R; Sugiyama Y; Tetta C; Thasler WE; Vanhaecke T; Vinken M; Weiss TS; Widera A; Woods CG; Xu JJ; Yarborough KM; Hengstler JG
Arch Toxicol; 2013 Aug; 87(8):1315-530. PubMed ID: 23974980
[TBL] [Abstract][Full Text] [Related]
13. Cryopreserved primary hepatocytes as a constantly available in vitro model for the evaluation of human and animal drug metabolism and enzyme induction.
Hengstler JG; Utesch D; Steinberg P; Platt KL; Diener B; Ringel M; Swales N; Fischer T; Biefang K; Gerl M; Böttger T; Oesch F
Drug Metab Rev; 2000 Feb; 32(1):81-118. PubMed ID: 10711408
[TBL] [Abstract][Full Text] [Related]
14. Development of 3D dynamic flow model of human liver and its application to prediction of metabolic clearance of 7-ethoxycoumarin.
Choi K; Pfund WP; Andersen ME; Thomas RS; Clewell HJ; LeCluyse EL
Tissue Eng Part C Methods; 2014 Aug; 20(8):641-51. PubMed ID: 24294911
[TBL] [Abstract][Full Text] [Related]
15. Nanostructured self-assembling peptides as a defined extracellular matrix for long-term functional maintenance of primary hepatocytes in a bioartificial liver modular device.
Giri S; Braumann UD; Giri P; Acikgöz A; Scheibe P; Nieber K; Bader A
Int J Nanomedicine; 2013; 8():1525-39. PubMed ID: 23626466
[TBL] [Abstract][Full Text] [Related]
16. Development and characterization of a small-scale bioreactor based on a bioartificial hepatic culture model for predictive pharmacological in vitro screenings.
Schmitmeier S; Langsch A; Jasmund I; Bader A
Biotechnol Bioeng; 2006 Dec; 95(6):1198-206. PubMed ID: 16807928
[TBL] [Abstract][Full Text] [Related]
17. Molecular mechanisms underlying the dedifferentiation process of isolated hepatocytes and their cultures.
Elaut G; Henkens T; Papeleu P; Snykers S; Vinken M; Vanhaecke T; Rogiers V
Curr Drug Metab; 2006 Aug; 7(6):629-60. PubMed ID: 16918317
[TBL] [Abstract][Full Text] [Related]
18. Perifusion of co-cultured hepatocytes: optimization of studies on drug metabolism and cytotoxicity in vitro.
Gebhardt R; Wegner H; Alber J
Cell Biol Toxicol; 1996 Apr; 12(2):57-68. PubMed ID: 8738475
[TBL] [Abstract][Full Text] [Related]
19. Hepatocytes as a tool in drug metabolism, transport and safety evaluations in drug discovery.
Sahi J; Grepper S; Smith C
Curr Drug Discov Technol; 2010 Sep; 7(3):188-98. PubMed ID: 20843293
[TBL] [Abstract][Full Text] [Related]
20. HepaRG human hepatic cell line utility as a surrogate for primary human hepatocytes in drug metabolism assessment in vitro.
Lübberstedt M; Müller-Vieira U; Mayer M; Biemel KM; Knöspel F; Knobeloch D; Nüssler AK; Gerlach JC; Zeilinger K
J Pharmacol Toxicol Methods; 2011; 63(1):59-68. PubMed ID: 20460162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
